| mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.8 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.006 |
0.8 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |